IDEAYA Biosciences, Inc.IDYANASDAQ
Loading
Year-over-year SG&A expense growth
Latest
14.92%
↑ 25% vs avg
Percentile
P55
Within normal range
Streak
1 qtr
Consecutive declineStable
Average
11.91%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 14.92% |
| Q3 2025 | 15.07% |
| Q2 2025 | 7.90% |
| Q1 2025 | 19.96% |
| Q4 2024 | 18.13% |
| Q3 2024 | -6.11% |
| Q2 2024 | 30.39% |
| Q1 2024 | 17.97% |
| Q4 2023 | -12.11% |
| Q3 2023 | 13.16% |
| Q2 2023 | 13.80% |
| Q1 2023 | 2.81% |
| Q4 2022 | -9.54% |
| Q3 2022 | 32.00% |
| Q2 2022 | -20.32% |
| Q1 2022 | 13.78% |
| Q4 2021 | 2.39% |
| Q3 2021 | 5.83% |
| Q2 2021 | -0.14% |
| Q1 2021 | 28.93% |
| Q4 2020 | -5.47% |
| Q3 2020 | 1.22% |
| Q2 2020 | 15.34% |
| Q1 2020 | 27.29% |
| Q4 2019 | 2.00% |
| Q3 2019 | 15.50% |
| Q2 2019 | 15.12% |
| Q1 2019 | 16.00% |
| Q4 2018 | 75.23% |
| Q3 2018 | -4.72% |
| Q2 2018 | 34.68% |
| Q1 2018 | 0.00% |